Home Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults
Article
Licensed
Unlicensed Requires Authentication

Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults

  • Yong-Jae Lee , Hye-Ree Lee , Jung-Hyun Lee , Youn-Ho Shin and Jae-Yong Shim
Published/Copyright: December 7, 2009

Abstract

Background: Increased uric acid is associated with the metabolic syndrome, conditions linked to oxidative stress and insulin resistance. Non-alcoholic fatty liver disease (NAFLD) is now considered a hepatic manifestation of insulin resistance. However, little has been written regarding the association between uric acid and NAFLD.

Methods: We examined the association between uric acid and the presence of NAFLD in 3768 Koreans (2133 men, 1635 women; aged 20–75 years) in a health examination program. Uric acid quartiles were categorized separately as follows: Q1: ≤291.5, Q2: 291.6–333.1, Q3: 333.2–380.7, and Q4: ≥380.8 μmol/L for men; Q1: ≤202.2, Q2: 202.3–232.0, Q3: 231.1–267.7, and Q4: ≥267.8 μmol/L for women. Hepatic steatosis was diagnosed based on abdominal ultrasonographic findings by hyperechogenicity of liver tissue, difference of echogenicity between the liver and diaphragm, and visibility of vascular structures. The odds ratios (ORs) and 95% confidence intervals (CIs) for NAFLD were calculated across each quartile of serum uric acid.

Results: The prevalence of NAFLD was 25.8% (32.2% in men and 17.4% in women). After adjustment for age, body mass index (BMI), smoking, regular exercise, blood pressure, fasting plasma glucose (FPG), triglycerides, and high-density lipoprotein (HDL) cholesterol, the ORs (95% CIs) for NAFLD according to each quartile of uric acid were 1.00, 1.55 (1.13–2.14), 1.77 (1.30–2.41), and 2.01 (1.45–2.78) for men and 1.00, 0.69 (0.40–1.20), 1.12 (0.67–1.88), and 1.94 (1.21–3.13) for women.

Conclusions: Serum uric acid is independently associated with the presence of NAFLD, and uric acid may be a useful additional measure in assessing the risk of NAFLD in the clinical setting.

Clin Chem Lab Med 2010;48:175–80.


Corresponding author: Jae-Yong Shim, MD, MPH, PhD, Associate Professor, Department of Family Medicine, Yonsei University College of Medicine, 146-92 Dogok-dong, Gangnam-gu, Seoul, 135-720, Korea Phone: +82-2-2019-3482, Fax: +82-2-3463-3287,

Received: 2009-6-7
Accepted: 2009-9-29
Published Online: 2009-12-7
Published in Print: 2010-02-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Review
  2. Elevated serum γ-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer – a narrative review
  3. Minireview
  4. Artificial intelligence for diagnostic purposes: principles, procedures and limitations
  5. General Clinical Chemistry and Laboratory Medicine
  6. Association between serum alkaline phosphatase and C-reactive protein in the United States National Health and Nutrition Examination Survey 2005–2006
  7. Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults
  8. Plasma osteopontin concentrations in preeclampsia – is there an association with endothelial injury?
  9. Determination of globotriaosylceramide in plasma and urine by mass spectrometry
  10. Effect of inflammation induced by prolonged exercise on circulating erythroid progenitors and markers of erythropoiesis
  11. The Beckman DxI 800 prolactin assay demonstrates superior specificity for monomeric prolactin
  12. Stability of cerebrospinal fluid/serum glucose ratio and cerebrospinal fluid lactate concentrations over 24 h: analysis of repeated measurements
  13. O-β-N-acetyl-D-glucosaminidase in erythrocytes of Italian air force acrobatic pilots
  14. Validation and Outcome Studies
  15. Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis
  16. Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis
  17. Reference Values and Biological Variations
  18. Applicability of common reference intervals for serum creatinine concentrations to the Croatian population
  19. Laboratory reference intervals during pregnancy, delivery and the early postpartum period
  20. Determination of serum holotranscobalamin concentrations with the AxSYM active B12 assay: cut-off point evaluation in the clinical laboratory
  21. Definition of reference ranges for the platelet distribution width (PDW): a local need
  22. Cancer Diagnostics
  23. Mean leukocyte telomere length and risk of incident colorectal carcinoma in women: a prospective, nested case-control study
  24. Heat shock protein 27 is over-expressed in tumor tissues and increased in sera of patients with gastric adenocarcinoma
  25. Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levels
  26. A novel sensitive immunoassay by nucleic acid barcode dot and its application in the detection of prostate-specific antigen
  27. Prostate cancer screening: clinical impact of WHO calibration of Beckman Coulter Access® prostate-specific antigen assays
  28. Infectious Diseases
  29. Use of flow cytometry (Sysmex® UF-100) to screen for positive urine cultures: in search for the ideal cut-off
  30. Letters to the Editor
  31. Improving laboratory efficiencies through significant time reduction in the preanalytical phase
  32. Comparison of the Vitek 2 system with the CLSI broth microdilution, disk diffusion, and sterol quantitation methods for determining fluconazole susceptibility against Candida spp.
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.037/html?lang=en
Scroll to top button